Target intelligence / Profile preview

DNA-directed RNA polymerase III subunit H (POLR3H)

Target
POLR3H
Molecular classification
Enzyme (subunit of RNA polymerase III), Transcription factor (part of eukaryotic transcriptional machinery), Other (multi-subunit polymerase complex component)
01

Overview

DNA-directed RNA polymerase III subunit H (POLR3H) is a protein-coding subunit of the multi-protein RNA polymerase III complex, essential for the transcription of a variety of small non-coding RNAs including tRNAs, 5S rRNA, U6 snRNA, and other short RNAs fundamental to RNA maturation and cellular translation machinery. It is a peripheral part of the polymerase III complex, forms a mobile stalk (with CRCP/RPC9), and is crucial for transcription initiation. POLR3H also serves as a nuclear and cytosolic DNA sensor and plays a role in the innate immune system by detecting cytosolic non-self double-stranded DNA, which can trigger type I interferon and NF-κB signaling via the RIG-I pathway, particularly in response to certain viral infections. Mutations in POLR3H and other Pol III subunits are linked to tissue-specific genetic disorders including hypomyelinating leukodystrophy, cerebellar-retinal degeneration, and potentially increase susceptibility to some infections[1][2][3][6]. No direct pharmacological modulators or drugs targeting POLR3H are currently identified.

Other names
DNA-directed RNA polymerase III subunit RPC8RNA polymerase III subunit C8KIAA1665RPC22.9C25RNA polymerase III subunit 22.9 kDa subunitRNA nucleotidyltransferase (DNA-directed)polymerase (RNA) III (DNA directed) polypeptide H (22.9kD)polymerase (RNA) III subunit H
02

Biological functions

Transcription of small non-coding RNAs (tRNAs, 5S rRNA, U6 snRNA)RNA maturationHousekeeping cellular RNA synthesisInnate immune response (nuclear and cytosolic DNA sensing, type I interferon induction)
03

Disease associations

Neurodegenerative disease (linked to infantile cerebellar-retinal degeneration, optic atrophy, hypomyelinating leukodystrophy)Infection (involved in the sensing of viral and bacterial infection, e.g., Epstein-Barr virus-induced interferon response)Other (rare genetic syndromes associated with POLR3H mutations)
04

Safety considerations

Genetic variants may cause progressive neurodegenerative disease (e.g., hypomyelination, retinal degeneration, optic atrophy)[1][2]Loss of function likely results in embryonic lethality or severe cellular dysfunction given its essential role in basal RNA transcription[2]

Beyond the preview

Go deeper on DNA-directed RNA polymerase III subunit H (POLR3H).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-directed RNA polymerase III subunit H (POLR3H).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call